Business Context and Reporting Period
Company: Bond Laboratories, Inc. (Note: Metadata lists "FITLIFE BRANDS, INC." but the filing text identifies the registrant as Bond Laboratories, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: August 13, 2009
Reporting Period: Events occurring between August 4, 2009, and August 13, 2009.
Key Financial Metrics
This filing does not provide comprehensive financial statements (revenue, profit, cash flow, or margins). Specific financial data points disclosed include:
- Capital Raised: $200,000 in gross proceeds from an additional closing of a private placement on August 4, 2009.
- Total Investment: The total investment by Vicis Capital Master Fund under the Preferred Purchase Agreement is $1,950,000.
- Debt Limits: An amendment to the Series B Certificate of Designations permits the company to incur aggregate indebtedness up to $3,000,000 under specific conditions (working capital lines, acquisitions up to $750,000, or affiliate debt up to $500,000).
- Compensation: A new consulting agreement with a former executive includes payments of $10,000 per month through the end of 2009 and $5,000 per month through 2010.
Material Changes
The filing reports significant changes in capital structure and corporate governance:
- Securities Issuance: Issued 20 shares of 10% Cumulative Perpetual Series B Preferred Stock and 1,200,000 shares of Common Stock to Vicis Capital Master Fund.
- Warrant Exchange: Vicis exchanged 1,800,000 common stock purchase warrants for 900,000 shares of unregistered Common Stock.
- Executive Departure: Scott Landow resigned as Chief Executive Officer and Principal Accounting Officer effective August 16, 2009. He transitioned to New Product Manager and entered a consulting agreement.
- Executive Appointment: John S. Wilson assumed the role of President and Chief Executive Officer effective August 16, 2009.
- Board Changes: Elorian Landers was appointed as a member of the Board of Directors.
- Charter Amendment: Section 7 of the Series B Certificate of Designations was amended to modify voting requirements and establish specific debt incurrence limits.
Guidance, Outlook, and Risks
Management Commentary and Outlook: The Board anticipates utilizing John S. Wilson's expertise in the beverage business (formerly with The Coca-Cola Company) to expand development and distribution, specifically focusing on the brand extension of Fusion's "Resurrection" anti-hangover drink.
Risks and Contingencies: The filing includes a standard cautionary note regarding forward-looking statements. Management disclaims any duty to update these statements and warns that actual results may differ materially from projections due to inherent uncertainties in estimates regarding orders, sales, operating margins, and cash flow.
Investor Verification Checklist
- Verify the total outstanding share count of Common Stock and Series B Preferred Stock following the August 4 issuance and warrant exchange.
- Confirm the terms of the new consulting agreement with Scott Landow and the total financial obligation through 2010.
- Review the specific conditions under which the $3,000,000 debt limit can be utilized as defined in the amended Series B Certificate of Designations.
- Assess the strategic impact of John S. Wilson's appointment on the company's beverage division and the "Resurrection" product line.
- Check subsequent filings for any updates on the company's liquidity position, as this 8-K does not provide current cash balances.